Published in

Wiley, Arthritis and Rheumatology, 10(71), p. 1616-1625, 2019

DOI: 10.1002/art.40905

Links

Tools

Export citation

Search in Google Scholar

Reducing or Maintaining the Dose of Subcutaneous Tocilizumab in Patients With Rheumatoid Arthritis in Clinical Remission: A Randomized, Open-Label Trial.

Journal article published in 2019 by Raimon Sanmarti, Douglas J. Veale, Emilio Martin‐Mola, José María Álvaro‐Gracia, José Luis Pablos, Consuelo Díaz Miguel, José Manuel Rodríguez, José Román Ivorra, Helena Santos, Javier Pino, Antonio Fernández Nebro, Blanca Hernández, Federico Navarro, Juan Povedano, Antonio Juan Mas and other authors.
This paper is made freely available by the publisher.
This paper is made freely available by the publisher.

Full text: Download

Green circle
Preprint: archiving allowed
Upload
Orange circle
Postprint: archiving restricted
Upload
Red circle
Published version: archiving forbidden
Policy details
Data provided by SHERPA/RoMEO